ERCC1, defective mismatch repair status as predictive biomarkers of survival for stage III colon cancer patients receiving oxaliplatin-based adjuvant chemotherapy

Authors:

Abstract
Background: Methods: Results: Conclusion:

This publication has 32 references indexed in Scilit: